NEW DELHI : Serum Institute of India (SII), the local maker of the AstraZeneca/Oxford coronavirus vaccine, said on Sunday it intends to concentrate on meeting India's own immediate demand in the next two months before exporting to other interested countries.
Chief Executive Adar Poonawalla said in an interview after the shot was approved for emergency use in the world's second-most populous country, that exports might be possible after supplying the Indian government with an initial 100 million doses.
The Indian government just wants to ensure that "the most vulnerable people of the country get it first - I fully endorse and support that decision", he said.
SII is still waiting to strike a formal supply deal with the Indian government, but is expected to do so in the coming days.
Chief Executive Adar Poonawalla said in an interview after the shot was approved for emergency use in the world's second-most populous country, that exports might be possible after supplying the Indian government with an initial 100 million doses.
The Indian government just wants to ensure that "the most vulnerable people of the country get it first - I fully endorse and support that decision", he said.
SII is still waiting to strike a formal supply deal with the Indian government, but is expected to do so in the coming days.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
8 Comments on this Story
 | A Singh7 hours ago No exporting of vaccines till the entire Indian population is vaccinated. |
 | N.Murali10 hours ago What are the GOI and pollution department plans to destroy the used vials and syringes that are going to be generated after vaccination in large scale in India |
| Sunnyman 11 hours ago These should be laws against spreading fake news. Non scientific people like Sain have no right to comment on public media. If you dont like the vaccine dont take it and DIE. |